ARQT - Arcutis Biotherapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARQT is currently covered by 9 analysts with an average price target of $32.88. This is a potential upside of $15.73 (91.72%) from yesterday's end of day stock price of $17.15.

Arcutis Biotherapeutics 's activity chart (see below) currently has 61 price targets and 83 ratings on display. The stock rating distribution of ARQT is 17.95% HOLD and 82.05% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.17% with an average time for these price targets to be met of 64.6 days.

Highest price target for ARQT is $22, Lowest price target is $15, average price target is $17.57.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 07-Aug-2025. First documented stock forecast 25-Feb-2020.

Currently out of the existing stock ratings of ARQT, 7 are a HOLD (17.95%), 32 are a BUY (82.05%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$6.48 (41.75%)

$20

29 days ago
(07-Aug-2025)

3/21 (14.29%)

$7.88 (55.81%)

275

Hold

$18

$2.48 (15.98%)

$6

1 months 11 days ago
(25-Jul-2025)

1/3 (33.33%)

$3.14 (21.13%)

108

Buy

$19

$3.48 (22.42%)

$19

5 months 2 days ago
(03-Apr-2025)

0/4 (0%)

$2.84 (17.57%)

Buy

5 months 2 days ago
(03-Apr-2025)

1/1 (100%)

$9.67 (36.73%)

27

Hold

$15

$-0.52 (-3.35%)

$11

6 months 9 days ago
(27-Feb-2025)

3/5 (60%)

$2.2 (17.19%)

41

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?

On average it took 64.6 days on average for the stock forecasts to be realized with a an average price target met ratio 23.17

Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?

GRAIG SUVANNAVEJH

Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh works at MIZUHO and has 14 price targets and 11 ratings on ARQT

Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh with highest potential upside - $36.28

Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?

Nigel Dally with lowest potential downside - -$5.52

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?